Standard Dataset

Supplementary Data S1 from Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial [Dataset]

Description

Supplementary Data S1. Detailed description of the experimental and analytical methods used in this study.